Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard Levy, MD
Ampio Pharmaceuticals. Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central Research Associates, Inc.
Birmingham, Alabama, United States
- Core Orthopaedic Medical Center
Encinitas, California, United States
- St. Joseph Heritage
Fullerton, California, United States
- Westlake Medical Research
Thousand Oaks, California, United States
- Drug Studies America
Marietta, Georgia, United States
- Healthcare Research Netword
Blue Island, Illinois, United States
- Heartland Research Associates
Wichita, Kansas, United States
- Healthcare Network Research
Hazelwood, Missouri, United States
- Coastal Carolina Center at Lowcountry Orthopaedics
North Charleston, South Carolina, United States
- Tekton Research
Austin, Texas, United States
- Northwest Clinical Research Center
Bellevue, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Dec 2017
- Primary completion
- 4 Oct 2018
- Completion
- 4 Oct 2018
- Last update posted
- 3 Oct 2022
- Registered enrollment
- 94
- Registry id
- NCT03349645
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.